Back to Journals » OncoTargets and Therapy » Volume 9

RETRACTED ARTICLE: miR-139-5p regulates proliferation, apoptosis, and cell cycle of uterine leiomyoma cells by targeting TPD52

Authors Chen H, Xu H, Meng YG, Zhang Y, Chen JY, Wei XN

Received 20 March 2016

Accepted for publication 10 August 2016

Published 11 October 2016 Volume 2016:9 Pages 6151—6160

DOI https://doi.org/10.2147/OTT.S108890

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 6

Editor who approved publication: Dr Jianmin Xu



This paper has been retracted.

Chen H, Xu H, Meng YG, Zhang Y, Chen JY, Wei XN. Onco Targets Ther. 2016;9:6151–6160.

We, the Editor and Publisher of OncoTargets and Therapy are retracting the published article. Since publication, concerns have been raised about the integrity of the data in the article. In addition, images from Figure S1 were found to have been duplicated. Specifically,

  • The image for Figure S1, Culture A, α-actin, has been duplicated with the image for Figure S1, Culture B, α-actin.
  • The image for Figure S1, Culture A, Merge, has been duplicated with the image for Figure S1, Culture B, Merge.

When approached for an explanation, the authors have been unable to address the concerns raised and have not been able to provide sufficient supporting information. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The authors listed in this publication have been informed.

We have been informed in our decision-making by our editorial policies and the COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

Creative Commons License © 2016 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.